Stock Track | Zai Lab Plummets 5.21% on Disappointing Q4 Earnings, Wider Loss

Stock Track

Feb 28, 2025

Zai Lab Ltd (ZLAB.OQ) saw its shares plummet 5.21% in pre-market trading on Friday after the biopharmaceutical company reported a wider-than-expected loss for the fourth quarter and revenue that fell slightly short of Wall Street estimates.

The company reported an adjusted loss of $0.80 per share for the quarter ended December 31, higher than the analyst consensus estimate of a $0.65 loss per share. Revenue rose 64.8% year-over-year to $108.51 million, but missed analysts' expectation of $110.21 million.

Despite the disappointing quarterly results, analysts remain optimistic about Zai Lab's prospects, with 12 out of 12 analysts rating the stock as a "buy" or "strong buy." The average consensus price target for the stock stands at $50.00, representing significant upside potential from its current levels.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1115498827"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1115498827\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1115498827?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-28 09:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115498827","market":"hk","top_or_hot":-1,"title":"Stock Track | Zai Lab Plummets 5.21% on Disappointing Q4 Earnings, Wider Loss","media":"Stock Track","content":"<p>Zai Lab Ltd (ZLAB.OQ) saw its shares plummet 5.21% in pre-market trading on Friday after the biopharmaceutical company reported a wider-than-expected loss for the fourth quarter and revenue that fell slightly short of Wall Street estimates.</p>\n\n<p>The company reported an adjusted loss of $0.80 per share for the quarter ended December 31, higher than the analyst consensus estimate of a $0.65 loss per share. Revenue rose 64.8% year-over-year to $108.51 million, but missed analysts' expectation of $110.21 million.</p>\n\n<p>Despite the disappointing quarterly results, analysts remain optimistic about Zai Lab's prospects, with 12 out of 12 analysts rating the stock as a \"buy\" or \"strong buy.\" The average consensus price target for the stock stands at $50.00, representing significant upside potential from its current levels.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Zai Lab Plummets 5.21% on Disappointing Q4 Earnings, Wider Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Zai Lab Plummets 5.21% on Disappointing Q4 Earnings, Wider Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-28 09:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zai Lab Ltd (ZLAB.OQ) saw its shares plummet 5.21% in pre-market trading on Friday after the biopharmaceutical company reported a wider-than-expected loss for the fourth quarter and revenue that fell slightly short of Wall Street estimates.</p>\n\n<p>The company reported an adjusted loss of $0.80 per share for the quarter ended December 31, higher than the analyst consensus estimate of a $0.65 loss per share. Revenue rose 64.8% year-over-year to $108.51 million, but missed analysts' expectation of $110.21 million.</p>\n\n<p>Despite the disappointing quarterly results, analysts remain optimistic about Zai Lab's prospects, with 12 out of 12 analysts rating the stock as a \"buy\" or \"strong buy.\" The average consensus price target for the stock stands at $50.00, representing significant upside potential from its current levels.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09688","symbol_name":"再鼎医药","start_time":0,"source_url":"","article_id":"1115498827","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115498827","pubTimestamp":1740706397,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Zai Lab Ltd  saw its shares plummet 5.21% in pre-market trading on Friday after the biopharmaceutical company reported a wider-than-expected loss for the fourth quarter and revenue that fell slightly short of Wall Street estimates.The company reported an adjusted loss of $0.80 per share for the quarter ended December 31, higher than the analyst consensus estimate of a $0.65 loss per share. Revenue rose 64.8% year-over-year to $108.51 million, but missed analysts' expectation of $110.21 million.D","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09688":"再鼎医药"},"translate_title":"股票赛道再鼎医药因第四季度盈利令人失望、亏损扩大而暴跌5.21%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09688":1},"content_text":"Zai Lab Ltd (ZLAB.OQ) saw its shares plummet 5.21% in pre-market trading on Friday after the biopharmaceutical company reported a wider-than-expected loss for the fourth quarter and revenue that fell slightly short of Wall Street estimates.\nThe company reported an adjusted loss of $0.80 per share for the quarter ended December 31, higher than the analyst consensus estimate of a $0.65 loss per share. Revenue rose 64.8% year-over-year to $108.51 million, but missed analysts' expectation of $110.21 million.\nDespite the disappointing quarterly results, analysts remain optimistic about Zai Lab's prospects, with 12 out of 12 analysts rating the stock as a \"buy\" or \"strong buy.\" The average consensus price target for the stock stands at $50.00, representing significant upside potential from its current levels.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}